1. Home
  2. CTMX vs BALY Comparison

CTMX vs BALY Comparison

Compare CTMX & BALY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

N/A

Current Price

$4.77

Market Cap

596.2M

Sector

Health Care

ML Signal

N/A

Logo Bally's Corporation

BALY

Bally's Corporation

N/A

Current Price

$13.30

Market Cap

683.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
CTMX
BALY
Founded
2008
2004
Country
United States
United States
Employees
N/A
10000
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
596.2M
683.8M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
CTMX
BALY
Price
$4.77
$13.30
Analyst Decision
Strong Buy
Hold
Analyst Count
7
5
Target Price
$8.86
$15.40
AVG Volume (30 Days)
2.5M
79.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$138,103,000.00
$2,450,478,000.00
Revenue This Year
N/A
$6.47
Revenue Next Year
N/A
$6.48
P/E Ratio
$22.58
N/A
Revenue Growth
36.45
0.06
52 Week Low
$0.40
$8.46
52 Week High
$6.35
$20.74

Technical Indicators

Market Signals
Indicator
CTMX
BALY
Relative Strength Index (RSI) 43.75 43.02
Support Level $3.83 $13.07
Resistance Level $6.20 $14.88
Average True Range (ATR) 0.32 0.97
MACD -0.08 -0.01
Stochastic Oscillator 16.34 36.59

Price Performance

Historical Comparison
CTMX
BALY

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About BALY Bally's Corporation

Ballys Corp is a gaming, hospitality, and entertainment company with a portfolio of casinos and resorts and a growing omnichannel presence. It provides customers with physical and interactive entertainment and gaming experiences, including traditional casino offerings, iGaming, online bingo, sportsbook, and free-to-play (F2P) games. The company owns and operates, several casinos across the United States, one golf course in New York, one horse racetrack in Colorado, and Aspers Casino in the United Kingdom. Its Interactive International division, an interactive gaming operator concentrated in Europe, operates a lottery management and services business. The company's reportable segments are Casinos and Resorts, which derive key revenue, International Interactive and North America Interactive.

Share on Social Networks: